23 results
S-3ASR
AGIO
Agios Pharmaceuticals Inc
30 Apr 20
Automatic shelf registration
4:19pm
include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other
8-K
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
or transfer of Vorasidenib as samples or for a charitable purpose, including for any compassionate use or as “named patient sales”.
“Fiscal Year” means each … not include transfers or dispositions for charitable, promotional or sampling, pre-clinical, clinical, regulatory, or governmental purposes. If an Earn-Out
424B5
xwbrum8uiw7be8tw8
9 Dec 14
Prospectus supplement for primary offering
12:00am
DEFA14A
EX-2.1
6yrmlu53 lh
21 Dec 20
Additional proxy soliciting materials
9:17pm
424B5
zbr zw0dcl769z3n93c
11 Dec 14
Prospectus supplement for primary offering
12:00am
424B5
s1h9s
6 Nov 19
Prospectus supplement for primary offering
4:07pm
424B5
vj8apm
8 Nov 19
Prospectus supplement for primary offering
5:03pm
DEFM14A
ualbnk
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
0o1pn vb9m7tqb
29 Jan 21
Preliminary proxy related to merger
4:22pm